[EN] BENZENESULFONANILIDE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE SEROTONIN 5-HT6 RECEPTOR<br/>[FR] COMPOSÉS DE BENZENESULFONANILIDE POUR LE TRAITEMENT DE TROUBLES RÉPONDANT À LA MODULATION DU RÉCEPTEUR 5-HT6 DE LA SÉROTONINE
申请人:ABBOTT GMBH & CO KG
公开号:WO2010125136A1
公开(公告)日:2010-11-04
The present invention relates to novel benzenesulfonanilide compounds of the Formulae (I) and (I') and physiologically tolerated acid addition salts and the N-oxides thereof. The compounds possess valuable therapeutic properties and are particularly suitable, for treating diseases that respond to modulation of the serotonin 5-HT6 receptor. (I) (I') F wherein R1 is hydrogen or methyl; R2 is hydrogen or methyl and is positioned vicinal to the radical R1; R3 hydrogen, C1-C3 alkyl, halogen, C1-C3 alkoxy, fluorinated C1-C3 alkyl or fluorinated C1-C3 alkoxy; R4 is hydrogen, C1-C4 alkyl, C3-C4 cycloalkyl, C3-C4 cycloalkylmethyl or fluorinated C1-C4 alkyl; R5 is hydrogen, fluorine, chlorine, C1-C4 alkyl, fluorinated C1-C4 alkyl, C1-C4 alkoxy or fluorinated C1-C4 alkoxy; and R6 is hydrogen, fluorine or chlorine.
本发明涉及式(I)和(I')的新型苯磺酰胺化合物及其生理耐受的酸盐和N-氧化物。这些化合物具有有价值的治疗特性,特别适用于治疗对5-羟色胺5-HT6受体调节有反应的疾病。(I)(I')F其中,R1是氢或甲基;R2是位于基团R1邻位的氢或甲基;R3是氢,C1-C3烷基,卤素,C1-C3烷氧基,氟化C1-C3烷基或氟化C1-C3烷氧基;R4是氢,C1-C4烷基,C3-C4环烷基,C3-C4环烷基甲基或氟化C1-C4烷基;R5是氢,氟,氯,C1-C4烷基,氟化C1-C4烷基,C1-C4烷氧基或氟化C1-C4烷氧基;R6是氢,氟或氯。